Healthcare News Pharma Industry News

Power of cancer drugs may see boost by targeting newly ID’d pathway

Cells zealously protect the integrity of their genomes, because damage can lead to cancer or cell death. The genome – a cell's complete set of DNA – is most vulnerable while it is being duplicated before a cell divides. Cancer cells constantly are dividing, so their genomes are constantly in jeopardy.

Researchers at Washington University School of Medicine in St. Louis have identified a previously unknown signaling pathway cells use to protect their DNA while it is being copied.

Cells zealously protect the integrity of their genomes, because damage can lead to cancer or cell death. The genome – a cell's complete set of DNA – is most vulnerable while it is being duplicated before a cell divides. Cancer cells constantly are dividing, so their genomes are constantly in jeopardy.

Researchers at Washington University School of Medicine in St. Louis have identified a previously unknown signaling pathway cells use to protect their DNA while it is being copied.

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]